IOLCP IOL Chemicals and Pharmaceuticals Q3 FY25 results (Oct–Dec 2024) and concall
IOL Chemicals reported a flat Q3 FY25 with total income at ₹527 crores, a slight decrease YoY but stable QoQ. Net profit saw a QoQ improvement to ₹21 crores, and EBITDA margin also improved QoQ to 9.7%. The company declared an interim dividend of ₹4 per share and announced a stock split. However, pricing pressure, stagnant demand, and logistic challenges continue to impact revenue and margin growth, with API prices remaining subdued. The company anticipates some recovery in demand and prices from Q2 FY26 onwards.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 526 | 523 |
| EBITDA | 42 | 47 |
| Net profit | 19 | 21 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
